SEC Form EFFECT filed by Forma Therapeutics Holdings Inc.

10/18/22 12:15:07 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Notice of Effectiveness

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 17, 2022

Accession Number:

0001193125-22-262665

Submission Type:

POS AM

CIK:	0001538927
Company Name:	Forma Therapeutics Holdings, Inc.
File Number:	333-258174

Date	Price Target	Rating	Analyst
6/13/2022	$46.00 → $21.00	Overweight	Cantor Fitzgerald
11/12/2021	$54.00 → $40.00	Outperform	SVB Leerink
8/17/2021	$55.00 → $53.00	Buy	HC Wainwright & Co.
8/2/2021	$58.00	Buy	Craig Hallum

Recent Analyst Ratings for
$FMTX